Top

Published in:

Open Access 01-11-2012 | Review

Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region

Authors: MC Liberto, N Marascio, E Zicca, G Matera

Published in: BMC Infectious Diseases | Special Issue 2/2012

Abstract

The epidemiological status of HCV in Europe, and in particular in Mediterranean countries, is continuously evolving. The genotype distribution is related to improvement of healthcare conditions, expansion of intravenous drug use and immigration. We review and characterize the epidemiology of the distribution of HCV genotypes within Calabria, an area of Southern Italy. We focus on the pattern of distinct HCV genotype changes over the last 16 years; particularly subtype 1b and genotype 4. We collected data by evaluating a hospital-based cohort of chronic hepatitis C patients; in addition, we report an update including new patients enrolled during last eight months.

Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, Dillion JF, Flisiak R, Forns X, Frankova S, Goldis A, Goulis I, Halota W, Hunyady B, Lagging M, Largen A, Makara M, Manolakopoulos S, Marcellin P, Marinho RT, Pol S, Poynard T, Puoti M, Sagalova O, Sibbel S, Simon K, Wallace C, Young K, Yurdaydin C, et al: A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011, 31 (Suppl 2): 30-60.CrossRefPubMed

Esteban JI, Sauleda S, Quer J: The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008, 48: 148-162. 10.1016/j.jhep.2007.07.033.CrossRefPubMed

Lavanchy D: Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011, 17: 107-115. 10.1111/j.1469-0691.2010.03432.x.CrossRefPubMed

Echevarría JM, León P, Pozo F, Avellón A: Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996–2004). Enferm Infecc Microbiol Clin. 2006, 24: 20-25. 10.1157/13083370.CrossRefPubMed

Fernández-Arcás N, López-Siles J, Trapero S, Ferraro A, Ibáñez A, Orihuela F, Maldonado J, Alonso A: High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol. 2006, 78: 1429-1435. 10.1002/jmv.20706.CrossRefPubMed

Altuglu I, Soyler I, Ozacar T, Erensoy S: Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis. 2008, 12: 239-244. 10.1016/j.ijid.2007.07.003.CrossRefPubMed

Keskın F, Çıftçı S, Türkoğlu S, Badur S: Transmission routes for chronic hepatitis C and its relation with HCV genotypes. Turk J Gastroenterol. 2010, 21: 396-400.PubMed

Savvas SP, Koskinas J, Sinani C, Hadziyannis A, Spanou F, Hadziyannis SJ: Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat. 2005, 12: 551-557. 10.1111/j.1365-2893.2005.00614.x.CrossRefPubMed

Raptopoulou M, Touloumi G, Tzourmakliotis D, Nikolopoulou G, Dimopoulou M, Giannoulis G, Vasiliadis T, Skoutelis A, Anagnostou O, Hatzis G, Manolakopoulos S: Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia. 2011, 15: 26-31.PubMedCentralPubMed

10.

Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G: Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005, 76: 327-332. 10.1002/jmv.20376.CrossRefPubMed

11.

Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, Leone G, Bonfiglio C, Lanzilotta E, Manghisi OG, Leandro G, NUTRIHEP Collaborating Group, Donnaloia R, Fanelli V, Mirizzi F, Parziale L, Crupi G, Detomaso P, Labbate A, Zizzari S, Depalma M, Polignano A, Lopinto D, Daprile G: Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009, 104: 2740-2746. 10.1038/ajg.2009.428.CrossRefPubMed

12.

Sereno S, Perinelli P, Laghi V: Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started. J Clin Virol. 2009, 45: 354-357. 10.1016/j.jcv.2009.04.022.CrossRefPubMed

13.

Pizzillo P, Almasio PL, Ferraro D, Craxi A, Di Stefano R: HCV genotypes in Sicily: is there any evidence of a shift?. J Med Virol. 2009, 81: 1040-1046. 10.1002/jmv.21498.CrossRefPubMed

14.

Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O: Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping. Anticancer Res. 2007, 27: 1219-1222.PubMed

15.

Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Crocè L, Tiribelli C, Campello C: Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol. 2002, 68: 352-356. 10.1002/jmv.10210.CrossRefPubMed

16.

Matera G, Lamberti A, Quirino A, Focà D, Giancotti A, Barreca GS, Guadagnino V, Liberto MC: Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis. 2002, 42: 169-173. 10.1016/S0732-8893(01)00350-9.CrossRefPubMed

17.

Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M: Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology. 1997, 26: 1006-1011. 10.1002/hep.510260431.CrossRefPubMed

18.

Sánchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M, Macias J, Lissen E: Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol. 1997, 27: 25-29. 10.1016/S0168-8278(97)80275-9.CrossRefPubMed

19.

Marascio N, Matera G, Quirino A, Giancotti A, Barreca GS, Lamberti AG, Caroleo B, Liberto MC, Focà A: Eleven-year distribution pattern of hepatitis C virus in southern Italy. J Pathog. 2012, 2012: 631095-PubMedCentralPubMed

20.

Kamal SM, Nasser IA: Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology. 2008, 47: 1371-1383. 10.1002/hep.22127.CrossRefPubMed

Title: Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region
Authors: MC Liberto
N Marascio
E Zicca
G Matera
Publication date: 01-11-2012
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue Special Issue 2/2012
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/1471-2334-12-S2-S4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2012

Chronic HCV infection: epidemiological and clinical relevance

Top topics in HCV research arena

Future research and collaboration: the “SINERGIE” project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?

Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies

Natural history and clinical response: “It’s the virus, stupid, or is it the host?”

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials